Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Español
English
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Volume 3 – Number 1
2026
>
Volume 3 - Number 1
Disease awareness in hemophilia: impact on therapeutic adherence and clinical outcomes
2026
>
Volume 3 - Number 1
Spanish registry of real-world clinical practice in previously untreated or minimally treated patients with severe hemophilia A (RePUM-HA)
2026
>
Volume 3 - Number 1
Indirect comparison of gene therapies in hemophilia A with use of generative artificial intelligence
2026
>
Volume 3 - Number 1
Prophylaxis in hemophilia A: beyond PK – the potential role of procoagulant platelet in the hemostatic activity of rFVIII a
2026
>
Volume 3 - Number 1
Beyond the factor: the present of hemophilia as innovation in medicine
2026
>
Volume 3 - Number 1
Inhibitors in hemophilia B in the era of extended half-life FIX concentrates: a case report